They found higher T-tau and P-tau and lower Aβ42 concentrations in Alzheimer disease patients with epilepsy compared with Alzheimer disease patients without epilepsy, suggesting that development of epilepsy is associated with a more pronounced neurodegenerative Alzheimer disease process. The gene discussed is MAPT; the disease is Alzheimer disease.